KEGG   DRUG: Vofatamab
Entry
D11445                      Drug                                   
Name
Vofatamab (USAN)
Formula
C6496H10040N1716O2050S44
Exact mass
146296.1844
Mol weight
146386.352
Sequence
(Heavy chain)
EVQLVESGGG LVQPGGSLRL SCAASGFTFT STGISWVRQA PGKGLEWVGR IYPTSGSTNY
ADSVKGRFTI SADTSKNTAY LQMNSLRAED TAVYYCARTY GIYDLYVDYT EYVMDYWGQG
TLVTVSSAST KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF
PAVLQSSGLY SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP
APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK
PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT
LPPSREEMTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL
TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCRASQDVD TSLAWYKQKP GKAPKLLIYS ASFLYSGVPS
RFSGSGSGTD FTLTISSLQP EDFATYYCQQ STGHPQTFGQ GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H154-H210, H230-L214, H236-H'236, H239-H'239, H271-H331, H377-H435, H'22-H'96, H'154-H'210, H'230-L'214, H'271-H'331, H'377-H'435, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Efficacy
Antineoplastic, Anti-FGFR-3 antibody
  Type
Monoclonal antibody
Comment
Treatment of relapsed or refractory advanced urothelial cell carcinoma (UCC)
Target
FGFR3 (CD333) [HSA:2261] [KO:K05094]
Brite
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   FGFR family
    FGFR3 (CD333)
     D11445  Vofatamab (USAN)
Other DBs
CAS: 1312305-12-6
PubChem: 384585422
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system